Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis

NCT04831333 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-07-21

No results posted yet for this study

Summary

Ophthalmological screening for cytomegalovirus retinitis (CMVR) for HIV/AIDS patients is important. However, the manual screening with fundus imaging is laborious and subjective.

Deep learning (DL) system has been developed for the automated detection of various eye diseases with high accuracy and efficiency, including diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), papilledema, lattice degeneration and retinal breaks, from ocular fundus photographs. UWF imaging is a relatively new imaging modality for DL system but has also shown extraordinary talents in automatic retinal analysis With the press for routine CMVR screening in AIDS patients and the great capacity of DL system, the use of deep learning (DL) system to AIDS-related CMVR with Ultra-Widefield (UWF) fundus images is promising.

The investigators previously developed a DL system to detect AIDS-related CMVR. For further evaluating the applicability of the DL system, a prospective dataset is needed.

Conditions

  • Cytomegalovirus Retinitis

Interventions

OTHER

Sponsors & Collaborators

  • Beijing Tongren Hospital

    collaborator OTHER
  • Kuifang Du

    lead OTHER

Principal Investigators

  • Kui-Fang Du · Beijing YouAn Hospital

  • Li Dong · Beijing Tongren Hospital

  • Kai Zhang · Beijing Tongren Hospital

  • Chao Chen · Beijing YouAn Hospital

  • Lian-Yong Xie · Beijing YouAn Hospital

  • Wen-Jun Kong · Beijing YouAn Hospital

  • Hong-Wei Dong · Beijing YouAn Hospital

  • He-Yan Li · Beijing Tongren Hospital

  • Rui-Heng Zhang · Beijing Tongren Hospital

  • Wen-Da Zhou · Beijing Tongren Hospital

  • Hao-Tian Wu · Beijing Tongren Hospital

  • Wen-Bin Wei · Beijing Tongren Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04831333 on ClinicalTrials.gov